A B S T R A C T Most of the immunoreactive growth hormone (IRGH) in human plasma elutes from Sephadex G-75 as "little" GH (LGH), mol wt 22,000, but 14-39% elutes earlier ("big" GH, BGH). In saline extracts of human pituitary, 11-17% of IRGH eluted as BGH. On gel filtration of pituitary and plasma BGH in 8 M urea, 59-81% ran as LGH, but when the remaining BGH was refiltered in urea, all ran as BGH. Thus there is a "urea-stable" and a "urealabile" form of BGH. Similarly, freezing and thawing converted over half of pituitary and plasma BGH to LGH, but when the "freeze-stable" BGH was again frozen, thawed, and refiltered, almost all ran as BGH. Urea-stable BGH was not dissociated by freezing, and most of the freeze-stable BGH was stable in urea, so the two forms are very similar or identical. Since 8 M urea and freezing dissociate peptides linked by noncovalent bonds, probably the BGH that is dissociated by urea and freezing consists of LGH bound noncovalently to another moiety, while in stable BGH the LGH is bound to another molecule by covalent or unusually strong noncovalent linkage. On centrifugation, the sedimentation of urea-stable BGH was consistent with a mol wt about twice that of LGH. Trypsinization of urea-stable BGH converted 36-59% to LGH, suggesting that some BGH may be a "prohormone" of LGH. On retrypsinization of the BGH that was not converted to LGH, only 13-24% converted, suggesting that there may be two forms of urea-stable BGH which vary in their response to trypsin.
INTRODUCTION
In a previous study, we investigated the possibility that immunoreactive growth hormone (IRGH) 1 in human plasma is composed of more than one molecular species (1) . The work was prompted in part by earlier studies on this subject by Bala, Ferguson, and Beck (2) , and by Berson and Yalow (3) . Plasma from acromegalic and normal subjects was fractionated on Sephadex G-75, and IRGH was measured in the effluent fractions. In every sample studied, almost all of the IRGH was found in two discrete peaks. In every instance the more retarded component ("little" IRGH, LGH) migrated almost identically with the major component of radioiodinated human pituitary GH (mol wt 22,000), while "big" IRGH (BGH) migrated at a rate consistent with a molecular size about twice that of LGH. BGH constituted 14-28% of total IRGH in the plasma of the acromegalics and 25-28% in the normal subjects. Two peaks of IRGH, indistinguishable from plasma BGH and LGH, were observed on gel filtration of "clinical grade" human pituitary GH. Similar results have been reported by Gorden, Lesniak, Hendricks, and Roth (4, 5) .
In our study, on rechromatography of LGH and of BGH freshly isolated from plasma, there was no conversion of one form to the other (1) . However, some conversion of BGH to LGH was noted in preparations of BGH stored at -200C.
In the present investigation, we have extracted BGH from saline extracts of human pituitary as well as from normal and acromegalic plasma, and have attempted to define some of its characteristics. The results of the study indicate that there are at least two distinct 1Abbreviatiois used in this paper: B/F, bound/free; BGH, big IRGH; GH, growth hormone; HGH, human GH; IRGH, immunoreactive GH; LGH, little IRGH; p, pituitary.
forms of BGH in plasnma and in pituitary extracts, an( suggest the possibility that one of these forms may bN a precursor or "prohormone" of LGH.
METHODS
Gel filtration. Gel filtration was carried out as previously described (1) , with the following modifications. Human gamma globulin (Miles Laboratories, Inc., Miles Research Div., Kankakee, Ill.) was iodinated with "2I by a modification of the method of Hunter and Greenwood (6) , and added to the plasma and pituitary samples before gel filtration to serve as a column marker. The other column markers employed were ['1l ]albumin and [V'I]sodium iodide obtained from E. R. Squibb & Sons, Princeton, N. J., and "25I-labeled LGH. The latter was prepared from "5I-labeled pituitary GH (pHGH) obtained from Cambridge Nuclear Corp., Cambridge, Mass., by filtering the material through a 2.5 X 80-cm Sephadex G-75 column as previously described (1) , counting the 125I in the effluent tubes, and pooling the fractions of the major peak, which eluted at a point consistent with a mol wt of approximately 22,000.
In the studies in which gel filtration was carried out in urea, urea (Fisher Scientific Co., Pittsburgh, Pa.) was dissolved in the filtration sample to a concentration of 8 M, and the sample was placed on a column containing Sephadex G-75 equilibrated with 8 M urea in 0.04 M barbital buffer, pH 8.2, containing 0.3% albumin. The sample was run through the column at 25'C at a rate of 10-20 mI/h, with the same solution.
In the preparation of BGH from the plasma of subject A. F. for gel filtration in urea, 10 ml of plasma was gelfiltered in barbital buffer on three separate occasions, the effluent fractions containing the BGH were pooled, and the pool was concentrated from an initial volume of 60 ml to 10 ml by pressure dialysis through an Amicon UM-2 filtration membrane (Amicon Corp., Lexington, Mass.). In experiments in which effluent fractions containing urea were subsequently gel-filtered in the absence of urea, the urea was removed from the pooled fractions by dialysis against the albumin-containing barbital buffer with a cellulose dialysis membrane with a pore diameter of 4.8 nm (Fischer Scientific Co.). The immunochemical grade pHGH used in this study was obtained from the National Institute of Arthritis, Metabolism and Digestive Diseases, Bethesda, Md.
GH radjoioin unoassay. The radioimmunoassay procedure was used as outlined previously (1) Per- formed in this manner, the assay was sensitive to 0.125 ng/assay tube. Where greater sensitivity was required, the assay tubes were incubated without 1'I for 3-4 days, at which time the iodinated hormone was added, and the tubes were incubated an additional 1-2 days before separation. Under these conditions, the assay was usually sensitive to 0.015 ng/assay tube. As we have observed that urea affects the results of our radioimmunoassay for HGH, in assays of effluent samples containing 8 M urea, we added 0.2 ml of the effluent diluted appropriately in the urea-cond taining buffer to each assay tube, and 0.2 ml of the ureae containing buffer to the standard tubes.
The method we employed for investigation of immunochemical identity by serial dilution has been described previously (1 The tubes were then centrifuged at 50,000 rpm for 17 h at 13'C in a Beckman L2-65 centrifuge with an SW-50 rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). 30 fractions of approximately 0.16 ml each were then collected from the bottom of each gradient tube and aliquots of these fractions were assayed for IRGH, 131I, and "I. It was found that the amounts of sucrose and NaCl carried over to the assay tubes in these studies had no effect on the immunoassay.
Trypsinization studies. Trypsinization of selected fractions of IRGH were performed by adding chymotrypsinfree trypsin (Sigma Chemical Co., St. Louis, Mo.) in varying concentrations to solutions of IRGH in the albumincontaining barbital buffer, and incubating for 30-45 min at 37' C. The trypsin was then inactivated by the addition of soy bean trypsin inhibitor (Sigma Chemical Co.) to a final concentration twice that of the trypsin.
RESULTS
Gel filtration of saline and barbital extracts of human pituitary. The gel filtration pattern of a saline extract of human pituitary (subject J. L.) is illustrated in Fig. 1A , and two discrete peaks of IRGH are apparent. The major peak, representing 79% of the total IRGH in the effluent, migrated identically with iodinated pHGH and thus was identical in its migration pattern to LGH in plasma (1) . The (Table I) . When the BGH obtained from the saline extract of patient J. L. was rechromatographed, 89% ran as BGH (Fig. 1B) .
Filtration of BGH in urea. The effect of 8 M urea on BGH was studied because this material is known to have the capacity to dissociate peptide subunits held together by noncovalent bonds (8) . When BGH extracted from the pituitary of J. L. (Fig. 1A ) was refiltered in 8 M urea, 60% migrated as LGH, eluting at the same point as iodinated pHGH, while the remainder ran as BGH (Fig. 1C) .' A portion of the material that ran as BGH in the presence of urea ("urea-stable" BGH) was then refiltered in 8 M urea and all of it ran as BGH (Fig. 1D ). Very similar results were obtained in a study of the BGH fraction 2In the presence of urea, the albumin, BGH, LGH, and
[125I]pHGH all eluted earlier than in the absence of urea, and this effect of urea has been observed for other proteins as well (9) . However, the relation of these fractions remained the same, in that LGH eluted at the same point as the (Fig. 2) . When plasma BGH was refiltered in barbital buffer 40 h after it had been extracted from plasma into the buffer, 30% ran as LGH (Fig. 2B) , and when the same fraction of BGH was filtered in 8 M urea, 63% ran as LGH (Fig. 2C) . However, when the ureastable fraction of BGH in Fig. 2C was refiltered in 8 M urea, all of it maintained its identity as BGH (Fig. 2D) (10) . To investigate further the possibility that there are two discrete forms of BGH, an aliquot of the BGH that had been extracted from the pituitary of J. L. (Fig.  1A ) was subjected to repeated freezing and thawing and then refiltered in barbital buffer, and it was found that 57% of the IRGH migrated as LGH with 43% eluting as BGH (Fig. 4A) . The fraction of BGH that proved to be freeze-stable was again subjected to freeze-thaw treatment and refiltered in barbital, and 82% of it maintained its identity as BGH (Fig. 4B) megalic plasma (Fig. 5) . When BGH from plasma was refiltered in barbital after 40 h of storage in barbital at 4VC, 48% ran as LGH (Fig. 5B) , and when an aliquot of the same BGH was refiltered after repeated freezing and thawing, 71% ran as LGH (Fig.  5C ). However, when the freeze-stable fraction of BGH was again subjected to repeated freezing and thawing, and refiltered in barbital, all of it ran as BGH (Fig.  5D ). LGH with either 1.0 or 1.5 jg/ml trypsin. An aliquot of urea-stable BGH was prepared from a saline extract of human pituitary (subject H. L.) by the methods described previously, and the material was dialyzed against barbital buffer to free it of urea. Trypsin was added to one portion in a concentration of 1 jug/ml and it was incubated for 30 min at 370 C, after which 2 Fug/ml soy bean trypsin inhibitor was added. To a second portion, we added the trypsin inhibitor and trypsin simultaneously, before the 30-min incubation, and hence this portion was not exposed to effective trypsinization. Both aliquots were then gel- filtered in barbital buffer. In the sample of trypsinized BGH, 36% ran as LGH, indicating that trypsin had converted some of the BGH to LGH (Fig. 8A) , whereas in the untrypsinized sample, almost all of the BGH retained its identity (Fig. 8B) . Similarly, trypsinization of urea-stable BGH from a saline extract of the pituitary of another subject (J. L.) converted 48% of the BGH to LGH; trypsinization of ureastable BGH from immunochemical grade HGH converted 44% to LGH; and trypsinization of urea-stable BGH from the plasma of an acromegalic patient (B. L.) converted 59% to LGH.
Since a large fraction of urea-stable BGH was not converted to LGH by trypsinization (Fig. 8A) , the possibility was considered that urea-stable BGH may consist of two separate components, which differ in their response to trypsin. To investigate this possibility, an aliquot of the BGH that retained its identity after trypsinization ("TSB" in Fig. 8A ) was again exposed to trypsin and only 13% was converted to LGH (Fig.   8C ). For comparison, in a simultaneous experiment an aliquot of BGH, not exposed to effective trypsinization previously, was treated with trypsin under identical conditions, and 42% was converted to LGH (Fig.  8D) . In two other experiments in which initial treatment with trypsin converted 48-52% of urea-stable pituitary BGH to LGH, on re-exposure of the trypsinstable BGH to trypsin, there was only 14-24% conversion to LGH.
To further study this problem, we performed an additional study, depicted in Fig. 9 . An aliquot of ureastable BGH was trypsinized with conversion of 51% to LGH (Fig. 9A ). An aliquot of the BGH that maintained its identity despite trypsinization ("TSB" in Fig. 9A ) was then retrypsinized and only 16% was converted to LGH (Fig. 9B) . The BGH that maintained its identity after this second trypsinization ("TSB" in Fig. 9B ) was again exposed to trypsin and essentially the same proportion, 17%, was converted to LGH (Fig. 9C ). These observations suggest that urea-stable BGH may consist of at least two components, one readily convertible by trypsin to LGH, and a second less readily convertible.
We next attempted to determine if trypsinization converted some of the urea-stable BGH to a urea-labile form. A portion of urea-stable BGH was trypsinized and on gel filtration, 40% ran as LGH. The portion that maintained its identity as BGH after trypsinization was then run on the column in 8 M urea and only 4% of it eluted as LGH. Thus trypsin does not appear to transform urea-stable BGH to a form of BGH that dissociates in urea.
LGH generated by trypsinization of urea-stable BGH from pituitary was compared with LGH found in an untreated saline extract of pituitary, and in a dilution study it was found to have a similar B/F curve (Fig.  3C) . DISCUSSION As illustrated in Table I , we have found a major component of LGH and minor component of BGH in every sample of human plasma and pituitary we have studied. These include plasma samples from eight acromegalic and four normal subjects, one barbital and two saline extracts of pituitary, and clinical grade and immunochemical grade preparations of pituitary GH.
In the present study, it was observed that over half of the BGH complex found in the pituitary and plasma migrated as LGH after exposure to 8 M urea (Figs. 1C and 2C) or after repeated freezing and thawing (Figs. 4A and 5C ). The fraction of BGH not susceptible to dissociation by urea appears to be very similar to or identical with the fraction not converted to LGH by freezing, for all of a sample of urea-stable BGH was found to be freeze-stable, and most of an aliquot of Both forms of the BGH complex elute from Sephadex at a point consistent with a molecular size about twice that of LGH. However, factors other than size can affect the migration of proteins on gel filtration (11) , and therefore we turned to centrifugation as an alternative means of molecular sizing. In the study illustrated in Fig. 7A , we centrifuged urea-stable BGH in a sucrose gradient and found its sedimentation rate to be consistent with a mol wt of 40,500, almost twice that of LGH, consistent with the results obtained on Sephadex chromatography.
It is possible that the form of BGH dissociated by urea and by freezing may consist at least in part of the dimer form of LGH, for it is known that LGH dimerizes to some extent when allowed to stand in concentrations over 5 mg/ml (12) , and the intracellular concentration of GH in the human pituitary probably exceeds this level (13) . Since the dimer form of LGH dissociates slowly when allowed to stand in low concentration (12) , this cound account for the tendency of extracted BGH to undergo partial conversion to LGH on prolonged standing in barbital buffer. It is also possible that some of the urea-labile form of BGH may consist of LGH bound by noncovalent bonds to some other peptide, in which case this form of BGH would then be analogous to thyroid-stimulating hormone, luteinizing hormone, and chorionic gonadotropin (14) .
To investigate the nature of the urea-stable BGH extracted from pituitary, we exposed a portion of this fraction to trypsin and it was observed that mild trypsinization converted 36-52% of it to LGH. Similarly, 59% of urea-stable BGH from a sample of acromegalic plasma was converted to LGH by trypsin. The LGH generated by trypsinization of pituitary BGH probably is very similar to or identical with the LGH present in untreated pituitary extracts, for in addition to having the same filtration characteristics, both forms have the same B/F curves (Fig. 3) and Stachura in human pituitary, which appears to have a molecular weight of over 200,000 (19, 20) .
In repeated experiments, trypsin converted 36-52% of urea-stable pituitary BGH to LGH, but when the BGH not converted by initial trypsinization was retrypsinized under the same conditions, only 13-24% was converted to LGH. In one experiment, a portion of BGH that had been exposed to trypsin twice was exposed a third time, and again 17% was converted to LGH (Fig. 8) . These observations suggest that there may be two forms of urea-stable BGH, one of which is less readily dissociated by trypsin than the other.
In the present study, we have directed our attention to the fraction of IRGH eluting from Sephadex between albumin and LGH, which we have designated BGH. However, there is also a fraction of IRGH in plasma and in pituitary extracts that elutes with or before albumin, noted by us as well as by Berson and Yalow (3), Bala, Ferguson, and Beck (2), and Gorden, Hendricks, and Roth (4). In our study this material, which generally appears as a broad "shoulder" rather than a peak, has comprised on the average only 3% of total IRGH in plasma and 4% in the pituitary extracts. It may represent aggregates of LGH or BGH, or consist of LGH bound to some other moiety. Some of it may be identical with the very large IRGH identified by Frohman, Burek, and Stachura (19, 20) .
We do not currently know the biological and clinical significance of the existence of multiple forms of BGH. Gorden et al. have recently found that the BGH complex of human pituitary and plasma is much less effective than LGH in displacing 'I-labeled pituitary LGH from the GH receptors of cultured human lymphocytes (5) . In unpublished work, we have performed receptor assay studies on preparations of BGH complex containing 40-51% urea-stable BGH, derived from saline extracts of two pituitaries and from immunochemical grade HGH (NIH).' These three BGH complex preparations were found to be 31-40% as effective as LGH in displacing ['I] LGH from cell membrane receptors of pregnant rabbit liver, by the method of Tsushima and Friesen (21) . In contrast, the ureastable BGH derived from these BGH complex preparations was 62-65% as effective as LGH. Similarly, in receptor assay studies employing cell membranes from pregnant rabbit mammary gland (22) and from rat liver (21) 
